![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center
Caption: Engineered to specifically link with the body’s immune fighters (T-cells) on one side, and a cancer cell on the other, the bispecific T-cell engager (BiTE) serves as a connector that tethers cancer to its killer.
Credit: Duke Medicine
Usage Restrictions: None
Related news release: Duke Medicine News new immune therapy successfully treats brain tumors in mice
|